Smith & Nephew plc (SNN)
USD 24.89
(-2.16%)
USD 24.89
(-2.16%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.54 Billion USD | 6.4% |
| 2022 | 5.21 Billion USD | 0.06% |
| 2021 | 5.21 Billion USD | 14.3% |
| 2020 | 4.56 Billion USD | -11.25% |
| 2019 | 5.13 Billion USD | 4.77% |
| 2018 | 4.9 Billion USD | 2.92% |
| 2017 | 4.76 Billion USD | 2.06% |
| 2016 | 4.66 Billion USD | 0.76% |
| 2015 | 4.63 Billion USD | 0.37% |
| 2014 | 4.61 Billion USD | 6.11% |
| 2013 | 4.35 Billion USD | 5.17% |
| 2012 | 4.13 Billion USD | -3.11% |
| 2011 | 4.27 Billion USD | 7.77% |
| 2010 | 3.96 Billion USD | 5.04% |
| 2009 | 3.77 Billion USD | -0.76% |
| 2008 | 3.8 Billion USD | 12.82% |
| 2007 | 3.36 Billion USD | 21.23% |
| 2006 | 2.77 Billion USD | 8.89% |
| 2005 | 2.55 Billion USD | 6.57% |
| 2004 | 2.39 Billion USD | 13.75% |
| 2003 | 2.1 Billion USD | 17.76% |
| 2002 | 1.78 Billion USD | 13.49% |
| 2001 | 1.57 Billion USD | -7.06% |
| 2000 | 1.69 Billion USD | -6.45% |
| 1999 | 1.81 Billion USD | 3.61% |
| 1998 | 1.74 Billion USD | 0.92% |
| 1997 | 1.73 Billion USD | -5.37% |
| 1996 | 1.83 Billion USD | 15.46% |
| 1995 | 1.58 Billion USD | 5.16% |
| 1994 | 1.5 Billion USD | 7.46% |
| 1993 | 1.4 Billion USD | 7.88% |
| 1992 | 1.3 Billion USD | -12.19% |
| 1991 | 1.48 Billion USD | 5.25% |
| 1990 | 1.4 Billion USD | 23.53% |
| 1989 | 1.13 Billion USD | 5.76% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2.82 Billion USD | 0.0% |
| 2023 Q2 | 2.73 Billion USD | 0.0% |
| 2023 Q4 | 2.79 Billion USD | 0.0% |
| 2023 FY | 5.54 Billion USD | 6.4% |
| 2022 Q2 | 2.6 Billion USD | 0.0% |
| 2022 FY | 5.21 Billion USD | 0.06% |
| 2022 Q4 | 2.74 Billion USD | 0.0% |
| 2021 Q2 | 2.59 Billion USD | 0.0% |
| 2021 FY | 5.21 Billion USD | 14.3% |
| 2021 Q4 | 2.63 Billion USD | 0.0% |
| 2020 Q4 | 2.47 Billion USD | 0.0% |
| 2020 FY | 4.56 Billion USD | -11.25% |
| 2020 Q2 | 2.03 Billion USD | 0.0% |
| 2019 Q2 | 2.48 Billion USD | 0.0% |
| 2019 Q4 | 2.68 Billion USD | 0.0% |
| 2019 FY | 5.13 Billion USD | 4.77% |
| 2018 Q2 | 2.44 Billion USD | 0.0% |
| 2018 FY | 4.9 Billion USD | 2.92% |
| 2018 Q4 | 2.46 Billion USD | 0.0% |
| 2017 FY | 4.76 Billion USD | 2.06% |
| 2017 Q2 | 2.33 Billion USD | 0.0% |
| 2017 Q4 | 2.42 Billion USD | 0.0% |
| 2016 Q4 | 2.34 Billion USD | 0.0% |
| 2016 Q2 | 2.32 Billion USD | 0.0% |
| 2016 FY | 4.66 Billion USD | 0.76% |
| 2015 FY | 4.63 Billion USD | 0.37% |
| 2015 Q4 | 2.36 Billion USD | 0.0% |
| 2015 Q2 | 2.27 Billion USD | 0.0% |
| 2014 Q2 | 2.22 Billion USD | 0.0% |
| 2014 Q4 | 2.39 Billion USD | 0.0% |
| 2014 FY | 4.61 Billion USD | 6.11% |
| 2013 Q2 | 2.14 Billion USD | 0.0% |
| 2013 FY | 4.35 Billion USD | 5.17% |
| 2013 Q4 | 2.2 Billion USD | 0.0% |
| 2012 Q1 | 1.07 Billion USD | -2.44% |
| 2012 Q4 | 1.07 Billion USD | 13.13% |
| 2012 Q2 | 1.02 Billion USD | -4.63% |
| 2012 Q3 | 952 Million USD | -7.48% |
| 2012 FY | 4.13 Billion USD | -3.11% |
| 2011 Q2 | 1.07 Billion USD | 2.09% |
| 2011 FY | 4.27 Billion USD | 7.77% |
| 2011 Q4 | 1.1 Billion USD | 7.17% |
| 2011 Q3 | 1.03 Billion USD | -4.18% |
| 2011 Q1 | 1.05 Billion USD | -1.12% |
| 2010 FY | 3.96 Billion USD | 5.04% |
| 2010 Q4 | 1.06 Billion USD | 13.39% |
| 2010 Q3 | 941 Million USD | -1.88% |
| 2010 Q2 | 959 Million USD | -3.62% |
| 2010 Q1 | 995 Million USD | -6.66% |
| 2009 Q3 | 915 Million USD | -1.19% |
| 2009 Q2 | 926 Million USD | 7.05% |
| 2009 Q1 | 865 Million USD | -9.9% |
| 2009 Q4 | 1.06 Billion USD | 16.5% |
| 2009 FY | 3.77 Billion USD | -0.76% |
| 2008 Q4 | 960 Million USD | 3.23% |
| 2008 Q2 | 1 Billion USD | 9.77% |
| 2008 Q3 | 930 Million USD | -7.0% |
| 2008 Q1 | 911 Million USD | -5.79% |
| 2008 FY | 3.8 Billion USD | 12.82% |
| 2007 Q2 | 813 Million USD | 9.27% |
| 2007 Q1 | 744 Million USD | -3.5% |
| 2007 Q3 | 845 Million USD | 3.94% |
| 2007 Q4 | 967 Million USD | 14.44% |
| 2007 FY | 3.36 Billion USD | 21.23% |
| 2006 Q2 | 686 Million USD | 6.69% |
| 2006 FY | 2.77 Billion USD | 8.89% |
| 2006 Q4 | 771 Million USD | 13.55% |
| 2006 Q3 | 679 Million USD | -1.02% |
| 2006 Q1 | 643 Million USD | 262.53% |
| 2005 Q1 | 628 Million USD | -11.08% |
| 2005 Q3 | 601.63 Million USD | -4.15% |
| 2005 Q4 | -395.62 Million USD | -165.76% |
| 2005 Q2 | 627.65 Million USD | -0.05% |
| 2005 FY | 2.55 Billion USD | 6.57% |
| 2004 Q3 | 556.55 Million USD | -0.33% |
| 2004 FY | 2.39 Billion USD | 13.75% |
| 2004 Q4 | 706.27 Million USD | 26.9% |
| 2004 Q1 | 556.58 Million USD | -12.49% |
| 2004 Q2 | 558.39 Million USD | 0.33% |
| 2003 Q3 | 513.9 Million USD | -0.51% |
| 2003 Q1 | 438.89 Million USD | 41.94% |
| 2003 Q4 | 636.02 Million USD | 23.76% |
| 2003 FY | 2.1 Billion USD | 17.76% |
| 2003 Q2 | 516.53 Million USD | 17.69% |
| 2002 FY | 1.78 Billion USD | 13.49% |
| 2002 Q2 | 401.31 Million USD | -11.65% |
| 2002 Q3 | 503.34 Million USD | 25.42% |
| 2002 Q4 | 309.21 Million USD | -38.57% |
| 2002 Q1 | 454.24 Million USD | 36.02% |
| 2001 Q4 | 333.94 Million USD | -10.42% |
| 2001 Q1 | 388.22 Million USD | -40.19% |
| 2001 FY | 1.57 Billion USD | -7.06% |
| 2001 Q3 | 372.77 Million USD | -3.9% |
| 2001 Q2 | 387.89 Million USD | -0.09% |
| 2000 Q2 | 416.31 Million USD | -11.76% |
| 2000 FY | 1.69 Billion USD | -6.45% |
| 2000 Q3 | 304.59 Million USD | -26.84% |
| 2000 Q1 | 471.8 Million USD | 3.76% |
| 2000 Q4 | 649.07 Million USD | 113.1% |
| 1999 Q2 | 454.6 Million USD | -2.05% |
| 1999 Q1 | 464.1 Million USD | 0.0% |
| 1999 FY | 1.81 Billion USD | 3.61% |
| 1999 Q4 | 454.72 Million USD | 1.56% |
| 1999 Q3 | 447.73 Million USD | -1.51% |
| 1998 FY | 1.74 Billion USD | 0.92% |
| 1997 FY | 1.73 Billion USD | -5.37% |
| 1996 FY | 1.83 Billion USD | 15.46% |
| 1995 FY | 1.58 Billion USD | 5.16% |
| 1994 FY | 1.5 Billion USD | 7.46% |
| 1993 FY | 1.4 Billion USD | 7.88% |
| 1992 FY | 1.3 Billion USD | -12.19% |
| 1991 FY | 1.48 Billion USD | 5.25% |
| 1990 FY | 1.4 Billion USD | 23.53% |
| 1989 FY | 1.13 Billion USD | 5.76% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Abbott Laboratories | 40.1 Billion USD | 86.165% |
| Allurion Technologies Inc. | 53.46 Million USD | -10278.364% |
| Artivion, Inc. | 354 Million USD | -1467.496% |
| Avanos Medical, Inc. | 673.3 Million USD | -724.15% |
| Butterfly Network, Inc. | 65.9 Million USD | -8320.334% |
| Butterfly Network, Inc. | 65.9 Million USD | -8320.334% |
| Bio-Rad Laboratories, Inc. | 2.67 Billion USD | -107.73% |
| Boston Scientific Corporation | 14.24 Billion USD | 61.032% |
| Perspective Therapeutics, Inc. | 7.1 Million USD | -78010.923% |
| CONMED Corporation | 1.24 Billion USD | -347.156% |
| Edwards Lifesciences Corporation | 6 Billion USD | 7.591% |
| Paragon 28, Inc. | 216.38 Million USD | -2464.363% |
| Glaukos Corporation | 314.71 Million USD | -1663.205% |
| Globus Medical, Inc. | 1.56 Billion USD | -253.783% |
| Inspire Medical Systems, Inc. | 624.79 Million USD | -788.126% |
| Integer Holdings Corporation | 1.59 Billion USD | -247.535% |
| Medtronic plc | 32.36 Billion USD | 82.854% |
| Nevro Corp. | 425.17 Million USD | -1205.113% |
| Owlet, Inc. | 54.01 Million USD | -10174.023% |
| Penumbra, Inc. | 1.05 Billion USD | -424.222% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Sonendo, Inc. | 43.86 Million USD | -12550.177% |
| STERIS plc | 5.13 Billion USD | -7.984% |
| Stryker Corporation | 20.49 Billion USD | 72.929% |
| Vapotherm, Inc. | 68.66 Million USD | -7980.793% |
| Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | 24.955% |